Immunological Safety and Effectiveness of the First Booster Dose of mRNA Vaccines Against COVID-19 in Kidney Transplant Recipients.

Clinical trial NCT05483725 · UNKNOWN

Trial details

NCT number: NCT05483725
Sponsor: Institute for Clinical and Experimental Medicine
Status: UNKNOWN
Study type: OBSERVATIONAL

Kidney Diseases Kidney Transplant; Complications COVID-19 Vaccine Adverse Reaction Rejection Acute Renal Rejection Chronic Renal

Start date: 2021-10-04
Primary completion: 2024-12-04
Enrollment: 108

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.